Research advances in PCSK9 inhibitors in ischemic stroke
10.19845/j.cnki.zfysjjbzz.2024.0129
- VernacularTitle:PCSK9抑制剂在缺血性脑卒中的研究进展
- Author:
Zhengjiao ZHOU
1
;
Zhiwen ZHOU
Author Information
1. 湖南师范大学临床医学院,湖南 长沙 410013
- Keywords:
PCSK9;
PCSK9 inhibitor;
Ischemic stroke;
Atherosclerosis
- From:
Journal of Apoplexy and Nervous Diseases
2024;41(7):668-672
- CountryChina
- Language:Chinese
-
Abstract:
PCSK9 inhibitors are a new type of drug used to reduce the level of low-density lipoprotein cholesterol.In recent years,PCSK9 inhibitors have exhibited certain potential in the treatment of ischemic stroke;however,the research in ischemic stroke is still in its early stages,and further studies are needed to confirm the safety and efficacy of PCSK9 in-hibitors.This article summarizes the mechanism of action of PCSK9 inhibitors in ischemic stroke in recent years and ana-lyzes their potential for future application.
